166Ho-DOTMP Skeletal Targeted Radiotherapy™ as conditioning for peripheral blood stem cell transplant for patients with multiple myeloma

被引:0
作者
Breitz, H
Wendt, R
Stabin, M
Shen, S
Rajendran, JG
Meredith, R
Martin, W
Serafini, A
Delpassand, E
Bensinger, W
Salzman, D
Ruffner, K
Goodman, M
Giralt, S
机构
[1] NEORX Corp, Seattle, WA 98119 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Vanderbilt Univ, Nashville, TN USA
[4] Univ Alabama, Ctr Canc, Birmingham, AL USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Univ Miami, Miami, FL 33152 USA
[7] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S291 / S292
页数:2
相关论文
共 50 条
[21]   Collection of Peripheral Blood Stem Cells in Patients with Multiple Myeloma after Stem Cell Transplant: A Single Institution Experience [J].
Swami, Umang ;
Dozeman, Lindsay ;
Tricot, Annick ;
Abbi, Kamal Kant Singh ;
Tricot, Guido J. .
BLOOD, 2015, 126 (23)
[22]   HO-166 DOTMP, A BONE SEEKING RADIOCHELATE FOR SELECTIVE MARROW RADIOTHERAPY WITH BONE-MARROW TRANSPLANTATION (BMT) FOR MULTIPLE-MYELOMA [J].
CHAMPLIN, R ;
DIMOPOULOS, M ;
BAYOUTH, J ;
MACEY, D ;
KASI, L ;
PRZEPIORKA, D ;
PODOLOFF, D ;
GARLICH, J ;
SIMON, J ;
ALEXANIAN, R .
BLOOD, 1993, 82 (10) :A266-A266
[23]   HO-166 DOTMP, A BONE SEEKING RADIOCHELATE FOR SELECTIVE MARROW RADIOTHERAPY WITH BONE-MARROW TRANSPLANTATION (BMT) FOR MULTIPLE-MYELOMA [J].
CHAMPLIN, R ;
DIMOPOULOS, M ;
BAYOUTH, J ;
MACEY, D ;
KASI, L ;
PRZEPIORKA, D ;
PODOLOFF, D ;
GARLICH, J ;
SIMON, J ;
ALEXANIAN, R .
EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) :1117-1117
[24]   A phase I/II study of 166Holmium-DOTMP in combination with high dose chemotherapy and autologous stem cell transplant (ASCT) for the treatment of patients with multiple myeloma (MM) [J].
Bensinger, W ;
Giralt, S ;
Eary, J ;
Podoloff, D ;
Holmberg, L ;
Alexanian, R ;
Goodman, M ;
Serafini, A ;
Thoelke, K ;
Bryan, JK ;
Champlin, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) :56-56
[25]   Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma [J].
Sahebi, F ;
Spielberger, R ;
Kogut, NM ;
Fung, H ;
Falk, PM ;
Parker, P ;
Krishnan, A ;
Rodriguez, R ;
Nakamura, R ;
Nademanee, A ;
Popplewell, L ;
Frankel, P ;
Ruel, C ;
Tin, R ;
Ilieva, P ;
Forman, SJ ;
Somlo, G .
BONE MARROW TRANSPLANTATION, 2006, 37 (09) :825-829
[26]   Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma [J].
F Sahebi ;
R Spielberger ;
N M Kogut ;
H Fung ;
P M Falk ;
P Parker ;
A Krishnan ;
R Rodriguez ;
R Nakamura ;
A Nademanee ;
L Popplewell ;
P Frankel ;
C Ruel ;
R Tin ;
P Ilieva ;
S J Forman ;
G Somlo .
Bone Marrow Transplantation, 2006, 37 :825-829
[27]   Efficacy and toxicity of a second autologous peripheral blood stem cell transplant for patients with relapsed or recurrent multiple myeloma [J].
Patel, R. C. ;
Burzynski, J. A. ;
Ochoa-Bayona, J. L. ;
Toro, J. ;
Greene, R. E. ;
Freytes, C. O. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) :57-57
[28]   Conditioning Chemotherapy with BORMEL in Autologous Stem Cell Transplant in Multiple Myeloma [J].
Alvarez, Jose L., Sr. ;
Pacheco, M. Augusta ;
Guzman, Pedro ;
Montoya, Leire ;
Mena, Veronica ;
Ortiz, Maricela ;
Jimenez, Rosa ;
Alvarado, Martha .
BLOOD, 2017, 130
[29]   High dose chemotherapy and peripheral blood stem cell transplant without the use of blood products in patients with multiple myeloma. [J].
Ford, PA ;
Gottshall, E ;
Matthews, BA ;
Henry, DH .
BLOOD, 2000, 96 (11) :420A-420A
[30]   The Efficacy and Course of Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma [J].
Bogucka-Fedorczuk, Aleksandra ;
Rybka, Justyna ;
Sawicki, Mateusz ;
Laszkowska-Lewko, Magdalena ;
Wicherska-Pawlowska, Katarzyna ;
Prajs, Iwona ;
Kuliczkowski, Kazimierz ;
Wrobel, Tomasz .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 :S341-S341